Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

currently with Boston Pharmaceuticals and Pfizer, which also involve 4-1BB bispecific proteins. Pfizer is developing SGN-BB228, a CD228/4-1BB candidate it inherited as part of its takeover of ...

12th May 2025 7:00 am RNS Transaction in Own Shares 9th May 2025 7:00 am RNS Transaction in Own Shares ...